Abstract:N, N-disubstituted glycosylated ureas have been synthesized in good-to-excellent yields by 1,4-conjugate addition of amines to glycosylated olefinic esters followed by reaction of resulting glycosyl β-amino esters with diisocyanates. The developed sugar-based molecules were well characterized by extensive standard spectroscopic analysis including NMR (1H, 13C, and DEPT), IR, MS, and elemental analysis and were screened for their biological activity against Mycobacterium tuberculosis (M. Tb.), where some of them displayed potent antitubercular activity. The molecules have been designed keeping in view the well-known inhibitors of the enzymes involved in the biosynthesis of mycobacterial cell wall polymers and may be further explored as lead molecules for the successful development of a potential antitubercular drug candidate.Dedicated to Dr. Rama P. Tripathi, Former Chief Scientist at CSIR-Central Drug Research Institute, Lucknow, India, for his extraordinary contribution to "Drug development against Tuberculosis"

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the development of new anti - tuberculosis drugs. Specifically, the authors synthesized a variety of glucose - based glycosylurea derivatives and evaluated their anti - tuberculosis activities against Mycobacterium tuberculosis (M. Tb.). The design of these compounds was inspired by known enzyme inhibitors that are involved in the biosynthesis of the cell wall polymers of Mycobacterium tuberculosis. By studying the structure - activity relationships (SAR) of these compounds, the authors hope to find lead molecules with potential anti - tuberculosis activities and provide a basis for the further development of effective anti - tuberculosis drugs. ### Background of the paper Tuberculosis (TB) is an infectious disease that is widely spread in developing countries, especially in India. This disease has a long history and requires long - term treatment. However, due to the emergence of multi - drug - resistant (MDR) and extensively - drug - resistant (XDR) tuberculosis strains, tuberculosis has become one of the major problems at present. Traditional first - line and second - line drugs are facing serious challenges due to the emergence of drug resistance, especially when tuberculosis is combined with HIV infection, the situation is even worse. Therefore, it is crucial to design new classes of anti - tuberculosis drugs to reduce the treatment time and the factors for the development of drug resistance. ### Research methods The authors synthesized N,N - disubstituted glycosylureas through the following steps: 1. **Synthesis of glycosyl β - amino esters**: Starting from D - glucose, through multiple standard synthesis steps, including 1,2; 5,6 - di - O - isopropyl protection, 3 - O - methylation, selective 5,6 - isopropyl deprotection, NaIO₄ oxidation and HEW enylation reaction, and finally the glycosyl β - amino esters were prepared through 1,4 - conjugate addition reaction. 2. **Synthesis of glycosylureas**: The above - mentioned glycosyl β - amino esters were reacted with diisocyanates to generate the required glycosylurea derivatives. 3. **Structural characterization**: The synthesized compounds were characterized in detail by means of nuclear magnetic resonance (NMR), infrared spectroscopy (IR), mass spectrometry (MS) and elemental analysis. 4. **Biological activity evaluation**: The anti - tuberculosis activities of the compounds against Mycobacterium tuberculosis were evaluated using the microplate blue assay (MABA) and the agar microdilution technique. ### Main findings - Most of the compounds did not show significant activity against Mycobacterium tuberculosis, and their minimum inhibitory concentration (MIC) values were greater than 25 or 50 μg/mL. - However, compounds 3a, 4b and 4c showed significant antimicrobial activities, and their MIC values were 12.5 μg/mL, indicating that these compounds have the potential to be developed into new anti - tuberculosis drugs. - Structure - activity relationship studies showed that the optimal hydrophilic and hydrophobic balance is crucial for improving the inhibitory effect. For example, compounds 4b and 4c have a hydrophilic hydroxyethyl substituent at the C - 5 position and a hydrophobic 3 - O - benzyl substituent, showing good anti - tuberculosis activities. ### Conclusion By synthesizing and characterizing a series of glucose - based glycosylurea derivatives, the authors found some lead molecules with potential anti - tuberculosis activities. Further optimization of these compounds is expected to develop new anti - tuberculosis drugs.

Synthesis and Antitubercular Evaluation of Diverse Glycosylated Ureas from D-Glucose

Exploration of isoxazole‐carboxylic acid methyl ester based 2‐substituted quinoline derivatives as promising antitubercular agents

Urea derivatives carrying a thiophenylthiazole moiety: Design, synthesis, and evaluation of antitubercular and InhA inhibitory activities

The structure–activity relationship of urea derivatives as anti-tuberculosis agents

Synthesis, Antitubercular Evaluation of New 2,3-(4-Aminobenzamido)benzoic Acid Derivatives

Synthesis and Anti-Mycobacterium Activity of Some New N-Rich Heterocyclic Derivatives and Their Molecular Docking, and DFT Studies

Design, synthesis, structure elucidation, antimicrobial, molecular docking, and SAR studies of novel urea derivatives bearing tricyclic aromatic hydrocarbon rings

Synthesis and Biological Evaluation of Arylthiourea Derivatives with Antitubercular Activity

Synthesis, characterisation, X-ray diffraction and biological evaluation of new thiourea derivatives against Mycobacterium tuberculosis and cervical cancer

Synthesis and biological evaluation of anti-tubercular activity of Schiff bases of 2-Amino thiazoles

Synthesis, urease inhibitory and anticancer evaluation of glucosamine-sulfonylurea conjugates

Synthesis and Biological Evaluation of Novel Benzhydrylpiperazine-Coupled Nitrobenzenesulfonamide Hybrids

Structure-based drug design and characterization of novel pyrazine hydrazinylidene derivatives with a benzenesulfonate scaffold as noncovalent inhibitors of DprE1 tor tuberculosis treatment

Design, synthesis, anti-tubercular activity, and computational studies of novel 3-(quinolin-3-yl)-1-phenylprop-2-en-1-one derivatives

Chemical synthesis and molecular modeling of novel substituted N-1,3-benzoxazol-2yl benzene sulfonamides as inhibitors of inhA enzyme and Mycobacterium tuberculosis growth

Synthesis and antimycobacterial activity of 1-(β-d-Ribofuranosyl)-4-coumarinyloxymethyl- / -coumarinyl-1,2,3-triazole

Synthesis, In Vitro and In Silico Evaluation of 3-(4, 5-Diphenyl-4H-1,2,4-triazol-3-yl)pyridine Derivatives As Potential Antimicrobial Agents

Targeted Hybridization: Pyrazine‐2‐Carbohydrazide Derivatives as Promising Antitubercular and Antimicrobial Leads

Antitubercular evaluation of dihydropyridine-triazole conjugates: design, synthesis, in vitro screening, SAR and in silico ADME predictions

Design, synthesis and biological evaluation of nitrofuran-1,3,4-oxadiazole hybrids as new antitubercular agents

Design, Synthesis, Evaluation of Antitubercular Activity and Insilco Studies of Novel 1,5‐Naphthyridin‐2(1H)‐one Pendent 1,2,3‐Triazoles